Peptide Synthesis Market to Grow with a CAGR of 6.08% through 2028
Increasing use of peptides in pharmaceutical and orphan drug
development is expected to drive the Global Peptide Synthesis Market growth in
the forecast period, 2024-2028.
According to TechSci Research report, “Global Peptide Synthesis
Market - Industry
Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Peptide
Synthesis Market stood at USD 419.07 Million in 2022 and is anticipated to grow
with a CAGR of 6.08% in the forecast period, 2024-2028. The rising demand for
peptide molecules in the healthcare and nutrition industries serves as a key
driver for the global peptide synthesis market. Additionally, the increasing
utilization of peptides in therapeutic drug production is expected to fuel market
growth in the coming years. Peptides are increasingly being employed in the
treatment of neurodegenerative and cardiovascular disorders, further contributing
to the expansion of the global peptide synthesis market. Advancements in
peptide synthesis technology have the potential to boost demand and propel
market growth in the future. Furthermore, government initiatives promoting the
benefits of peptide synthesis are anticipated to bolster overall market growth.
The global peptide synthesis
market is highly competitive, with the presence of well-established market
players who have achieved success through consistent results. These players are
expected to hold a significant share of the global market in the future. Growth
strategies such as novel product launches can provide a competitive advantage
to these established players in the peptide synthesis market. For instance,
US-based market player GenScript Biotech announced the launch of the
'Neoantigen Specific Peptide Synthesis Service' in April 2020, aimed at
precision immune-oncology therapeutic development in the next two years.
Prominent players in the peptide synthesis market could consider collaborating
with smaller players to expand their market presence and increase their revenue
shares. Research and development efforts are expected to be a key growth
strategy for established players in the peptide synthesis market. The
increasing adoption of peptide therapies, driven by cost-effectiveness,
efficiency, and lower toxicity, is a major factor contributing to market growth
in the pharmaceutical and biotechnology sectors.
Browse over 26 market data
Figures spread through 91 Pages and an in-depth TOC on "Global Peptide Synthesis Market”
Technological advancements in
peptide synthesizers and a strong pipeline of peptide therapeutics also
contribute to the market growth. For example, Science Direct published an
article in 2022 titled "Advances in oral peptide drug nanoparticles for diabetes
mellitus treatment," which highlighted the potential of oral
administration of peptide medications for the treatment of diabetes mellitus.
This approach is considered promising due to its ease and high patient
compliance compared to parenteral administration methods. Product launches,
mergers, and acquisitions among competitors are further boosting market growth.
In January 2022, Novo Nordisk India launched the world's first 'Peptide In A
Pill' for diabetes management, introducing Semaglutide, a GLP-1 receptor
analog, as a drug class for the management of type 2 diabetes. These
developments are expected to drive growth in the pharmaceutical and
biotechnology end-user segment of the peptide synthesis market.
Technological advancements in
recent years have brought about significant changes in the pharmaceutical
industry, leading to the utilization of synthetic peptides in pharmaceutical
medicines. Solid Phase Peptide Synthesis is increasingly being employed in
laboratories for the development of synthetic peptides, which play a crucial
role in the creation of innovative medications. The research activities
conducted on peptides have witnessed a notable increase, accompanied by the
growth of public and private entities engaged in synthetic biology research.
This trend is expected to fuel the market growth for peptides in the coming
years. However, a major challenge faced by the market is the lack of unified
regulations governing peptides, making it difficult for them to obtain
therapeutic approvals and limiting their application areas.
Moreover, the rising
prevalence of eye and skin disorders, coupled with increased research and
development activities, significantly impacts the growth of the studied market.
Cosmetic peptides, such as Acetyl Tetrapeptide-5 and Dipeptide-2, are widely utilized
in eye creams to address dark and puffy under-eye circles by improving
lymphatic circulation. Additionally, peptides like oligopeptide-34 and
nonapeptide-1 find application in the treatment of skin pigmentation. According
to a research article published in the Karger Journal in May 2021, individuals
with dark skin of South/Southeast Asian, Hispanic/Latin American, and African
descent have a high prevalence of pigmentary disorders. The same source
indicates that pigmentary disorders rank as the third and fourth most common
dermatoses in Blacks and Hispanics, respectively. Therefore, the high
prevalence of pigmentation disorders and the potential benefits of cosmetic
peptides in correcting skin pigmentation are expected to drive the cosmetic
peptide synthesis market during the forecast period.
Furthermore, numerous studies
have demonstrated the ability of peptides to promote wound healing, cell
migration, and angiogenesis. Cosmetic peptides find applications in eye care,
aging, and pigmentation benefits, and several clinical trials are being conducted
to validate their advantages. For instance, a clinical trial published in the
Clinical Aesthetic Dermatology Journal in May 2021 introduced an enhanced
peptide-based serum that combines five neuromodulating peptides. These peptides
target pre- and postsynaptic pathways at the neuromuscular junction to induce
muscle relaxation and attenuate facial expression, thereby minimizing the
formation of expression lines. Scientific evidence has shown that these
peptides have statistically significant effects in reducing the appearance of
facial lines, eye lines, and eye wrinkles during maximum smile and facial rest
relative to the baseline. The increasing number of trials utilizing cosmetic
peptides and the associated advantages are expected to drive market growth
during the forecast period.
Considering the rising demand
for cosmetic peptides across various applications and the continuous
introduction of new products, the studied market is anticipated to witness
growth over the analysis period. However, stringent regulations governing the
approval of cosmetic peptides are likely to pose challenges to market growth.
The Global Peptide Synthesis
Market is segmented into product, technology, application, end-user, regional
distribution, and company.
Based
on technology, the market is segmented into solid-phase peptide synthesis (SPPS),
solution-phase synthesis (SPS), liquid-phase peptide synthesis (LPPS). The
incorporation of automation in liquid phase peptide synthesis has significantly
reduced the cost of peptide synthesis, leading to the dominance of the liquid
phase peptide synthesis segment in the global peptide synthesis market. This is
expected to drive the global use of peptide synthesis and increase revenue
generation throughout the forecast period. According to standard research, SPPS
is a viable strategy for developing API processes and GMP manufacturing, as it
enables cost-effective synthesis of long peptide sequences (more than 10 amino
acids).
Based
on region, North America segment is expected to grow during the forecast
period. North America is expected to
emerge as the dominant region in the global peptide synthesis market due to the
growing awareness of peptide synthesis technologies among the population in
countries such as the US and Canada. Furthermore, the presence of major market
players in these countries is likely to contribute to the future growth of the
North American market.
Asia
Pacific is poised to offer lucrative growth opportunities for the global
peptide synthesis market, driven by the increasing prevalence of chronic
diseases in countries such as India. This is expected to fuel market growth in
the region.
Europe
is projected to witness strong growth in the overall peptide synthesis market,
primarily due to increased healthcare expenditure by governments in countries
such as the UK and Germany. The rest of the world is anticipated to experience
moderate growth in the global peptide synthesis market in the coming years.
Major companies operating in Global
Peptide Synthesis Market are:
- PolyPeptide Group
- Merck KGaA
- Thermo Fisher Scientific
- Enamine Ltd.
- Alfa Chemistry
- CEM Corporation
- GenScript
- AAPPTec
- Bachem Holding
- AnaSpec, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“There have been significant
technological advancements to facilitate the creation and synthesis of
peptides, which have gained considerable traction in the healthcare and
nutrition sectors. Both enzymatic and chemical peptide synthesis have followed
this trend. The market is experiencing growth due to the utilization of
peptides in the pharmaceutical and consumer healthcare sectors. Peptides have a
diverse range of applications in the treatment of cancer, diabetes, and
obesity, in addition to addressing other lifestyle issues. The increased
prevalence of these metabolic and lifestyle diseases has led to the wider
adoption of peptide treatments in oncology and metabolic illnesses.
Various companies are
implementing strategic initiatives such as partnerships and innovation in
cosmetic peptides, leading to the launch of products that fuel segment growth.
For example, in January 2021, BASF entered into an exclusive partnership with Caregen,
a Korean-based company engaged in biomimetic peptide research and development,
to create a series of patented cosmetic peptides in Asia. These peptides can
effectively address signs of aging, enhance skin brightness, soothe dry and
itchy skin, and provide moisturization for individuals of all age groups. The
development of such dermo-cosmetic peptides has the potential to revolutionize
the cosmetics industry, thereby driving segment growth during the analysis
period.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Peptide Synthesis Market- Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Product (Equipment, Reagents and Consumables, Others), By Technology
{Solid-Phase Peptide Synthesis (SPPS), Solution-Phase Synthesis (SPS),
Liquid-Phase Peptide Synthesis (LPPS)}, By Application (Therapeutics, Diagnosis,
Research), By End-User (Pharmaceutical and Biotechnology Companies, Contract
Manufacturing Organization (CMO), Academic and Research Institutes), By Region and Competition”, has evaluated the future
growth potential of Global Peptide Synthesis Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Peptide Synthesis Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com